Open pilot study phase IV to treat co infected HCV-HIV patients after their relapse with interferon therapy.Tratamiento de los pacientes con hepatitis crónica C infectados por el VIH que han recaído trás el tratamiento con terapias basadas en interferón:estudio piloto abierto. - PILOT NR
- Conditions
- CHRONIC HEPATITIS C
- Registration Number
- EUCTR2005-001192-34-ES
- Lead Sponsor
- Vicente Soriano-Hospital Carlos III. Madrid
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Authorised-recruitment may be ongoing or finished
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Adults patients age from 18 to 65
anti HCV positive (ELISA)
RNA HCV positive
HIV positive
relapser patient to interferon therapy
lymfocytes CD4+ >200 cel/hl
anti HBsAg negative
compensate hepatopathy
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
pregnancy woman
HBV
HIV treatment with ddI
alcoholic hepatitis
hepatoma
depresion
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method